↓ Skip to main content

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease

Overview of attention for article published in Cochrane database of systematic reviews, October 2006
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
155 Dimensions

Readers on

mendeley
102 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease
Published in
Cochrane database of systematic reviews, October 2006
DOI 10.1002/14651858.cd006257
Pubmed ID
Authors

Giovanni FM Strippoli, Carmen Bonifati, Maria E Craig, Sankar D Navaneethan, Jonathan C Craig

Abstract

Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor antagonists (AIIRA) are considered to be equally effective for patients with diabetic kidney disease (DKD), but renal and not mortality outcomes have usually been considered.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 102 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 99 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 24 24%
Researcher 14 14%
Student > Postgraduate 10 10%
Student > Bachelor 10 10%
Unspecified 9 9%
Other 34 33%
Unknown 1 <1%
Readers by discipline Count As %
Medicine and Dentistry 64 63%
Unspecified 11 11%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Nursing and Health Professions 5 5%
Social Sciences 4 4%
Other 11 11%
Unknown 1 <1%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2017.
All research outputs
#6,788,847
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#6,877
of 8,923 outputs
Outputs of similar age
#92,175
of 218,085 outputs
Outputs of similar age from Cochrane database of systematic reviews
#351
of 496 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 218,085 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 496 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.